Stockholm, Sweden – Pharmalink AB, a Swedish specialty pharma company, announces that it has appointed Heather Cook as director of regulatory affairs and Marek Poszepczynski as director of business development. [break]
Dr. Cook brings to Pharmalink more than 15 years of experience within the pharmaceutical industry, with a proven track record in global regulatory affairs and clinical development. Prior to joining Pharmalink, Dr. Cook was Head of Department for Regulatory Development Projects at H. Lundbeck A/S. She was also Global Regulatory Affairs Director, Oncology for Astra Zeneca and held a number of other senior roles including Scientific Director for Neuroscience and Infection.
Dr. Cook has worked in the UK, Canada, and Denmark and currently resides in Stockholm. Dr. Cook is also Partner, Pharma and Biotech R&D consultant at PharmaView Consulting HB. She has a PhD in Zoology from the University of Toronto and is completing an MBA at Stockholm School of Economics.
Mr. Poszepczynski joins Pharmalink after a career spanning 10 years and combining financial and business development experience. Before joining Pharmalink, Mr. Poszepczynski was lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks.
Prior to Handelsbanken, Mr. Poszepczynski was Vice President of Business Development at Karolinska
Development, where he carried out a wide variety of tasks including streamlining the
company’s business operations as well as taking part in M&A, licensing and fund
raising negotiations.
Mr. Poszepczynski spent six years at BioVitrum AB where he was Director of Corporate Development, and part of the in - October 29, 2012, Stockholm, Sweden – Pharmalink AB, a Swedish specialty pharma company, announces that it has appointed Heather Cook as director of regulatory affairs and Marek Poszepczynski as director of business development.
Article continues below
Dr. Cook brings to Pharmalink more than 15 years of experience within the pharmaceutical industry, with a proven track record in global regulatory affairs and clinical development. Prior to joining Pharmalink, Dr. Cook was Head of Department for Regulatory Development Projects at H. Lundbeck A/S. She was also Global Regulatory Affairs Director, Oncology for Astra Zeneca and held a number of other senior roles including Scientific Director for Neuroscience and Infection.
Dr. Cook has worked in the UK, Canada, and Denmark and currently resides in Stockholm. Dr. Cook is also Partner, Pharma and Biotech R&D consultant at PharmaView Consulting HB. She has a PhD in Zoology from the University of Toronto and is completing an MBA at Stockholm School of Economics.
Mr. Poszepczynski joins Pharmalink after a career spanning 10 years and combining financial and business development experience. Before joining Pharmalink, Mr. Poszepczynski was lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks.
Prior to Handelsbanken, Mr. Poszepczynski was Vice President of Business Development at Karolinska
Development, where he carried out a wide variety of tasks including streamlining the
company’s business operations as well as taking part in M&A, licensing and fund
raising negotiations. ■
LATEST MOVES FROM Stockholm, Sweden – Pharmalink AB, a Swedish specialty pharma company, announces that it has appointed Heather Cook as director of regulatory affairs and Marek Poszepczynski as director of business development. [break]
Dr. Cook brings to Pharmalink more than 15 years of experience within the pharmaceutical industry, with a proven
Predominant upper-level ridging stretching from the Southwest to the southern High Plains will allow for another day of record-breaking heat across parts of Nevada and Arizona today.